Table 4 Relations between changes in [11C]-raclopride BPND/types of stimulation and changes in strategy scores in SWM
Variable | Coeff. | SE | z | P > z | 95% CI |
|---|---|---|---|---|---|
[11C]-raclopride BPND | |||||
[11C]-raclopride BPND | −2.49 | 1.33 | −1.88 | 0.060 | −5.10–0.10 |
Age | −0.07 | 0.32 | −0.22 | 0.827 | −0.70–0.56 |
[11C]-raclopride BPND × age | 0.3 | 0.31 | 0.95 | 0.340 | −0.31–0.92 |
Stimulation | |||||
Stimulation (tDCS = 1/Sham = 0) | −1.77 | 0.58 | −3.02 | 0.003 | −2.91 to −0.61 |
Age | −0.05 | 0.36 | 0.14 | 0.886 | −0.66–0.76 |
Stimulation × age | −0.08 | 0.33 | −0.25 | 0.800 | −0.72–0.56 |